These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9507812)

  • 1. Hepatitis C virus: epidemiology, transmission and prevention.
    van der Poel CL; Ebeling F
    Curr Stud Hematol Blood Transfus; 1998; (62):208-36. PubMed ID: 9507812
    [No Abstract]   [Full Text] [Related]  

  • 2. The epidemiology of viral hepatitis in the United States.
    Alter MJ; Mast EE
    Gastroenterol Clin North Am; 1994 Sep; 23(3):437-55. PubMed ID: 7989088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C: no longer a diagnosis by exclusion.
    Molinari JA
    Compendium; 1994 Jun; 15(6):682, 684. PubMed ID: 7994724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 5. Iatrogenic hepatitis C virus transmission via commercial plasma donation in Spain.
    Davis AR
    Pathology; 1998 Nov; 30(4):427. PubMed ID: 9839323
    [No Abstract]   [Full Text] [Related]  

  • 6. [From non-A non-B hepatitis to hepatitis C].
    Couroucé AM
    Transfus Clin Biol; 1997; 4(3):287-90. PubMed ID: 9264787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A preliminary study of HCV infections with hemophilia and their family members].
    Sun HY; Li ZX; Liu WL; Xu HZ; Yang SH; Tang JZ; Hao LJ
    J Tongji Med Univ; 1994; 14(3):178-80. PubMed ID: 7528820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the research on non-A, non-B hepatitis in China].
    Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Dec; 12(6):377-9. PubMed ID: 1811901
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of hepatitis C virus infection in Europe and North America.
    Ebeling F
    Curr Stud Hematol Blood Transfus; 1994; (61):164-81. PubMed ID: 7956328
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimated risk of transmission of hepatitis C virus by blood transfusion.
    Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
    Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HCV antibodies in selected patient groups and blood donors].
    Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
    Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
    Takano S; Omata M; Ohto M; Nakamura K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion-associated non-A, non-B hepatitis: an assessment of the causative agent and its clinical impact.
    Alter HJ; Prince AM
    Transfus Med Rev; 1988 Dec; 2(4):288-93. PubMed ID: 2856531
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transmission of viruses (from A to E) and prevention].
    Jouanolle H; Brissot P
    Rev Prat; 1990 Jun; 40(18):1660-6. PubMed ID: 2115202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
    O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
    Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.